Advertisement
Screener

HIMS & HERS HEALTH, INC. (HIMS) Overview

HIMS & HERS HEALTH, INC. (HIMS) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.37; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.40; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.06; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.17; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$13.79$17.36$21.86$27.51$34.63$43.602025-11-062026-11-06$2.95$5.60$10.61$20.10$38.09$72.182021-11-082026-11-06$2.95$5.60$10.61$20.10$38.09$72.182019-09-132026-11-06$2.95$5.60$10.61$20.10$38.09$72.182019-09-132026-11-06$2.95$5.60$10.61$20.10$38.09$72.182019-09-132026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$26.00
Previous close
$28.70
Change
-$2.71
Change (%)
-9.43%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

HIMS
-11.61%
S&P 500
(m)

1 year

HIMS
-51.45%
S&P 500
(m)

3 years

HIMS
+356.28%
S&P 500
(m)

5 years

HIMS
+281.14%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.37

-0.48-0.27-0.050.160.3831 Mar 2025: estimate (m); actual 0.2031 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.1730 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.0630 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.4031 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.3730 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.37(m)(m)
1 Jan 202631 Mar 2026(m)-0.40(m)(m)
1 Jul 202530 Sept 2025(m)0.06(m)(m)
1 Apr 202530 Jun 2025(m)0.17(m)(m)
1 Jan 202531 Mar 2025(m)0.20(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.51

-0.66-0.320.030.370.7131 Dec 2021: estimate (m); actual -0.5831 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.3231 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.1131 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.5331 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.5131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.51(m)(m)
1 Jan 202431 Dec 2024(m)0.53(m)(m)
1 Jan 202331 Dec 2023(m)-0.11(m)(m)
1 Jan 202231 Dec 2022(m)-0.32(m)(m)
1 Jan 202131 Dec 2021(m)-0.58(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 753.21M ■ Earnings -86.29M — Profit margin -11.46%

-193.55M-16.1%155.85M-9.3%505.25M-2.5%854.65M4.3%30 Sept 2025: revenue 598.98M; earnings 15.77M; profit margin 2.63%30 Sept 202531 Dec 2025: revenue 617.82M*; earnings 20.60M*; profit margin 3.33%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 608.10M; earnings -92.11M; profit margin -15.15%31 Mar 202630 Jun 2026: revenue 753.21M; earnings -86.29M; profit margin -11.46%30 Jun 2026

31 Dec 2025 ■ Revenue 2.35B ■ Earnings 0.13B — Profit margin 5.47%

-0.36B-13.5%0.64B-5.8%1.64B1.9%2.64B9.5%31 Dec 2022: revenue 0.53B; earnings -0.07B; profit margin -12.46%31 Dec 202231 Dec 2023: revenue 0.87B; earnings -0.02B; profit margin -2.70%31 Dec 202331 Dec 2024: revenue 1.48B; earnings 0.13B; profit margin 8.54%31 Dec 202431 Dec 2025: revenue 2.35B; earnings 0.13B; profit margin 5.47%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$26.00(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$26.00High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

YouTube videos mentioning HIMS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-142.03M
Profit margin
-5.51%
Return on assets · 12 month
-5.16%
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
9.32M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-5.69%*
Total return · month
-0.49%*
Total return · quarter
-14.05%*
Total return · half year
48.09%*
Total return · year to date
-11.61%*
Total return · 1 year
-51.45%*
Total return · 3 years
356.28%*
Total return · 5 years
281.14%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$2.58B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

HIMS & HERS HEALTH, INC. Overview

View more →

(m)

(m)

SEC CIK
1773751
Industry (SIC)
8011 Services-Offices & Clinics of Doctors of Medicine
Country of operation
United States
Business address
2269 CHESTNUT ST, #523, SAN FRANCISCO, California, 94123, United States
Fiscal year end
1231
Phone
415-851-0195